Can B Corp. to Produce 13,000 Liters of Delta-8 and Other Isomers with Potential $10 Million Revenue
Can B Corp. (OTCQB:CANB) announced its new hemp processing agreement targeting the production of over 13,000 liters of Delta-8 and other isomers, with a market value exceeding $10 million. The company will utilize recently acquired facilities in Colorado to process harvested hemp biomass into winterized crude and subsequently into isolate. This acquisition aims to enhance cash flow and increase production capacity, with an estimated annual throughput of 2 million pounds of biomass. CEO Marco Alfonsi emphasized the milestone's significance for Can B's business growth.
- Secured a new hemp processing agreement with potential revenue exceeding $10 million.
- Newly acquired Colorado facilities will enhance production capacity and cash flow.
- Targeting an annual throughput of 2 million pounds of biomass processed into hemp isolate.
- None.
Newly acquired Colorado facilities will process isolate for Can B Products
HICKSVILLE, NY / ACCESSWIRE / September 15, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, announced today plans to fulfill a new hemp processing agreements after securing hemp biomass and winterized crude to create over 13,000 Liters (1 Liter = 1.05 Quarts) of isomers, including Delta-8, with a potential wholesale value exceeding
Hemp derived isomers are increasing rapidly in popularity as more hemp companies realize hemp-derived CBD can be used to create isomers such as CBN, CBC, and Delta 8. Can B believes it is on the cutting edge of Delta 8 production and it has the capacity to complete an increasing number of wholesale orders, as well as providing Delta 8 for its own retail products. Can B's newly acquired facilities in Colorado will receive harvested hemp biomass and convert it to winterized crude. These same facilities will then process it to distillate, then to isolate which will be shipped to Company-owned facilities in Florida and Tennessee to produce Delta-8 or other isomers, or to its manufacturing facility in Lacey WA for its line of CBD tinctures, salves, gels, and drops. This entire process cycle is expected to take 5-6 months to monetize the revenue.
Marco Alfonsi, Can B's Chief Executive Officer, commented, "This is a major milestone for our Company as we have completed our previously announced hemp isomer pipeline fulfillment. It's an extremely attractive deal for us, especially from a cash flow perspective, as we were able to acquire the biomass in a restricted stock transaction valued at a
At start-up production levels, the existing Company owned Colorado operation is targeting an annual throughput of 2.0 million pounds of biomass processed into hemp isolate.
About Can B Corp.
Can B Corp. (OTCQB:CANB) is a health & wellness company providing the highest quality hemp derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operate R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
Investors and Media:
IR@canbiola.com
(917) 658-7878
SOURCE: Can B Corp.
View source version on accesswire.com:
https://www.accesswire.com/664106/Can-B-Corp-to-Produce-13000-Liters-of-Delta-8-and-Other-Isomers-with-Potential-10-Million-Revenue
FAQ
What is Can B Corp.'s new hemp processing agreement about?
What is the expected revenue from Can B's new hemp processing?
Where are the newly acquired facilities located for Can B Corp.?